✦ LIBER ✦

P595 Anti-TNF alfa therapy in patients with inflammatory bowel disease and coronary syndrome: efficacy and safety

✍ Scribed by Indriolo, A.; Senni, M.; Ravelli, P.

Book ID: 123279344
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 55 KB
Volume: 7
Category: Article
ISSN: 1873-9946
DOI: 10.1016/S1873-9946(13)60616-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P494 Elderly patients with inflammatory

P494 Elderly patients with inflammatory bowel disease under anti-TNF therapy: efficacy and safety

✍ Lobaton Ortega, T.; Vermeire, S.; Ballet, V.; Rutgeerts, P.; Van Assche, G.; Fer 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 119 KB

P.02.19 ANTI-TNFALPHA THERAPY IN PATIENT

P.02.19 ANTI-TNFALPHA THERAPY IN PATIENTS WITH CORONARY SYNDROME AND INFLAMMATORY BOWEL DISEASE: EFFICACY AND SAFETY

✍ Indriolo, A.; Senni, M.; Signorelli, S.; Greco, S.; Ravelli, P. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Mo1179 Efficacy and Safety of Anti-TNF T

Mo1179 Efficacy and Safety of Anti-TNF Therapy in Elderly Patients With Inflammatory Bowel Disease

✍ Ortega, Triana Lobatón; Vermeire, Severine; Ballet, Vera; Rutgeerts, Paul J.; Va 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 514 KB

P062 TUBERCULOUS CHEMOPROPHYLAXIS REQUIR

P062 TUBERCULOUS CHEMOPROPHYLAXIS REQUIREMENTS AND SAFETY IN INFLAMMATORY BOWEL DISEASE PATIENTS PRIOR TO ANTI-TNF THERAPY

✍ Y. Zabana; E. Domènech; A. Lopez-Sanroman; B. Beltran; J.L. Cabriada; C. Saro; R 📂 Article 📅 2007 🏛 Oxford University Press ⚖ 61 KB

P448 Inflammatory and cancerous skin les

P448 Inflammatory and cancerous skin lesions in inflammatory bowel disease patients treated with anti-TNF therapy

✍ Ocepek, A.; Pernat Drobez, C. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 155 KB

Tuberculous chemoprophylaxis requirement

Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy

✍ Yamile Zabana; Eugeni Domènech; Antonio López San Román; Belén Beltrán; José Lui 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Background: Preventive actions are advised since the use of anti-tumor necrosis factor (TNF) agents is known to increase the risk of tuberculosis (TB). No data related to the effectiveness and safety of the preventive chemoprophylaxis (ChP) for TB in inflammatory bowel disease (IBD) patients are ava